Amundi Sells 1,431 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Amundi lowered its position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 21.1% in the 4th quarter, HoldingsChannel reports. The firm owned 5,360 shares of the biotechnology company’s stock after selling 1,431 shares during the quarter. Amundi’s holdings in Arrowhead Pharmaceuticals were worth $106,000 at the end of the most recent reporting […]
